SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-028844
Filing Date
2021-05-24
Accepted
2021-05-24 17:08:28
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_cmlifesciences2.htm 10-Q 299883
2 CERTIFICATION f10q0321ex31-1_cmlife2.htm EX-31.1 9180
3 CERTIFICATION f10q0321ex31-2_cmlife2.htm EX-31.2 9653
4 CERTIFICATION f10q0321ex32-1_cmlife2.htm EX-32.1 3885
5 CERTIFICATION f10q0321ex32-2_cmlife2.htm EX-32.2 4166
  Complete submission text file 0001213900-21-028844.txt   2250228

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cmii-20210331.xml EX-101.INS 275675
7 XBRL SCHEMA FILE cmii-20210331.xsd EX-101.SCH 37887
8 XBRL CALCULATION FILE cmii-20210331_cal.xml EX-101.CAL 17417
9 XBRL DEFINITION FILE cmii-20210331_def.xml EX-101.DEF 164301
10 XBRL LABEL FILE cmii-20210331_lab.xml EX-101.LAB 268986
11 XBRL PRESENTATION FILE cmii-20210331_pre.xml EX-101.PRE 168629
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40090 | Film No.: 21955960
SIC: 8731 Services-Commercial Physical & Biological Research